NUTM1 and acute lymphoblastic leukemia: While in KMT2A-rearranged infant ALL, age at diagnosis <6 months is associated with higher relapse risk, NUTM1-rearranged infants tended to be younger than NUTM1-wildtype/KMT2A-wildtype infants.